| APC | Antigen-presenting cell |
| BM | Bone marrow |
| BMT | Bone marrow transplantation |
| BST2 | Bone marrow stromal antigen 2 |
| CBT | Cord blood transplantation |
| cDCs | Conventional DCs |
| CLR | C-type lectin-like receptors |
| CRPC | Castration-resistant prostate cancer |
| CTLs | CD8+ cytotoxic T lymphocytes |
| CXCL | C-X-C motif chemokine ligands |
| CXCR3 | C-X-C motif chemokine receptor 3 |
| DCs | Dendritic cells |
| Flt3L | Fms-like tyrosine kinase 3-ligand |
| GM-CSF | Granulocyte-macrophage colony stimulating factor |
| HNSCC | Head and neck squamous cell carcinomas |
| HSPCs | Hematopoietic stem and progenitor cells |
| IDO | Immunoregulatory enzyme indoleamine 2,3-dioxygenase |
| IFN-I | Type I Interferon |
| IFNR | IFN receptor |
| IL-3 | Interleukin 3 |
| ILT7 | Immunoglobulin-like cell transcript 7 |
| IMQ | Imiquimod |
| IRF | Interferon Regulatory Factor |
| MHC | Major histocompatibility complex |
| moDCs | Monocyte-derived dendritic cells |
| NK | Natural killer |
| OS | Overall survival |
| PBMCs | Peripheral blood mononuclear cells |
| pDCs | Plasmacytoid DCs |
| PFS | Progression-free survival |
| PGE2 | Prostaglandin E2 |
| SLN | Sentinel lymph node |
| TAA | Tumor-associated antigens |
| TGF-β | Transforming growth factor- β |
| TILs | Tumor-infiltrating lymphocytes |
| TLR | Toll-like receptors |
| TME | Tumor microenvironment |
| TNF | Tumor necrosis factor |
| TRAIL-R2 | TRAIL receptor-2 |
| Treg | Regulatory T cells |